Literature DB >> 10653920

Mapping target site selection for the non-specific nuclease activities of retroviral integrase.

M Katzman1, M Sudol, J S Pufnock, S Zeto, L M Skinner.   

Abstract

To identify the parts of retroviral integrase that interact with its DNA substrates, we compared the patterns of target site usage by chimeric enzymes and protein fragments in assays that reveal integrase's non-specific nuclease activities. The central region of 12 chimeric proteins between the human immunodeficiency virus type 1 and visna virus integrases was found to be responsible for selecting non-viral target DNA sites when small alcohols provide the attacking nucleophilic OH group during non-specific alcoholysis assays. Testing deletion derivatives of the integrase protein in this assay, which has similarities to the DNA joining reaction that occurs during retroviral integration, defined a smaller central domain that is sufficient for activity. Thus, this core domain likely contains both the host DNA site and the nucleophile site. Surprisingly, the region of integrase responsible for selecting non-viral target DNA sites when the viral DNA end is the attacking nucleophile could not similarly be mapped with the standard oligonucleotide joining assay. We therefore tested the proteins in a more sensitive assay that displays preferred sites of viral DNA insertion in a plasmid DNA target. All 12 chimeras yielded novel patterns compared with the wild-type enzymes in this assay, although local insertion patterns indicated that the central domain plays an important role in target site selection. Together, these data suggest that other protein regions must be involved when the attacking nucleophilic group is provided by viral DNA. Because specific recognition of viral DNA ends was previously mapped to the central domain, two different regions of integrase must interact with retroviral DNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653920     DOI: 10.1016/s0168-1702(99)00126-4

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Authors:  Wesley M Konsavage; Stephen Burkholder; Malgorzata Sudol; Amy L Harper; Michael Katzman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

Authors:  C Calmels; V Richard de Soultrait; A Caumont; C Desjobert; A Faure; M Fournier; L Tarrago-Litvak; V Parissi
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

5.  Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.

Authors:  Zahida Parveen; Muhammad Mukhtar; Adrienne Goodrich; Edward Acheampong; Ralph Dornburg; Roger J Pomerantz
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Directed DNA shuffling of retrovirus and retrotransposon integrase protein domains.

Authors:  Xiaojie Qi; Edwin Vargas; Liza Larsen; Whitney Knapp; G Wesley Hatfield; Richard Lathrop; Suzanne Sandmeyer
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

7.  Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase.

Authors:  Olivier Delelis; Vincent Parissi; Hervé Leh; Gladys Mbemba; Caroline Petit; Pierre Sonigo; Eric Deprez; Jean-François Mouscadet
Journal:  PLoS One       Date:  2007-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.